Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke prevention.
Amarenco
Pierre
P
INSERM U-698 and Denis Diderot University-Paris VII, France. pierre.amarenco@bch.aphp.fr
Steg
Philippe Gabriel
PG
D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications*; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*